Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse

Science China Life Sciences

Volumn 58, Issue 2, 2015, Pages 208-211

  Yan, YiWu ^a   Liu, Qiang ^a   Li, Ning ^a   Du, JianChao ^a   Li, Xiao ^b   Li, Chang ^b   Jin, NingYi ^b   Jiang, ChengYu ^a,c  

^a TSINGHUA UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AVES;

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; LOSARTAN;

ACUTE LUNG INJURY; ANIMAL; AVIAN INFLUENZA; BIRD; C57BL MOUSE; DRUG EFFECTS; HOST PATHOGEN INTERACTION; INFLUENZA A VIRUS (H5N1); MORTALITY; ORTHOMYXOVIRIDAE INFECTIONS; PHYSIOLOGY; SURVIVAL; SURVIVAL RATE; VIROLOGY;

ACUTE LUNG INJURY; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BIRDS; HOST-PATHOGEN INTERACTIONS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; LOSARTAN; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 84924291273     PISSN: 16747305     EISSN: 18691889     Source Type: Journal    
DOI: 10.1007/s11427-015-4814-7     Document Type: Letter

References (14)

1. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature, 2012, 486: 420–428
2. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. Airborne transmission of influenza A/H5N1 virus between ferrets. Science, 2012, 336: 1534–1541
3. Peiris JS, Cheung CY, Leung CY, Nicholls JM. Innate immune responses to influenza A H 5N1: friend or foe? Trends Immunol, 2009, 30: 574–584
4. Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell M, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C, Penninger JM. A crucial role of angiotensin converting enzyme 2 (ACE2) in sars coronavirus-induced lung injury. Nat Med, 2005, 11: 875–879
5. Zou Z, Yan Y, Shu Y, Gao R, Sun Y, Li X, Ju X, Liang Z, Liu Q, Zhao Y, Guo F, Bai T, Han Z, Zhu J, Zhou H, Huang F, Li C, Lu H, Li N, Li D, Jin N, Penninger JM, Jiang C. Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections. Nat Commun, 2014, 5: 3594
6. Huang F, Guo J, Zou Z, Liu J, Cao B, Zhang S, Li H, Wang W, Sheng M, Liu S, Pan J, Bao C, Zeng M, Xiao H, Qian G, Hu X, Chen Y, Chen Y, Zhao Y, Liu Q, Zhou H, Zhu J, Gao H, Yang S, Liu X, Zheng S, Yang J, Diao H, Cao H, Wu Y, Zhao M, Tan S, Guo D, Zhao X, Ye Y, Wu W, Xu Y, Penninger JM, Li D, Gao GF, Jiang C, Li L. Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients. Nat Commun, 2014, 5: 3595
7. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev, 2000, 52: 11–34
8. Robles NR, Cerezo I, Hernandez-Gallego R. Renin-angiotensin system blocking drugs. J Cardiovasc Pharmacol Ther, 2014, 19: 14–33
9. Khan MG. Cardiac Drug Therapy. Springer, 2007
10. Raiden S, Nahmod K, Nahmod V, Semeniuk G, Pereira Y, Alvarez C, Giordano M, Geffner JR. Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome. J Pharmacol Exp Ther, 2002, 303: 45–51
11. Inada Y, Wada T, Shibouta Y, Ojima M, Sanada T, Ohtsuki K, Itoh K, Kubo K, Kohara Y, Naka T, et al. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2′-(1h-tetrazol-5-yl)biphenyl-4-yl]methyl]-1h-benzimidazole-7-carbo-xylate (TCV-116), in various hypertensive rats. J Pharmacol Exp Ther, 1994, 268: 1540–1547
12. Imai Y, Kuba K, Penninger JM. The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice. Exp Physiol, 2008, 93: 543–548
13. Fedson DS. How will physicians respond to the next influenza pandemic? Clin Infect Dis, 2014, 58: 233–237
14. Mortensen EM, Nakashima B, Cornell J, Copeland LA, Pugh MJ, Anzueto A, Good C, Restrepo MI, Downs JR, Frei CR, Fine MJ. Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes. Clin Infect Dis, 2012, 55: 1466–1473